BioNexus Gene Lab
BGLC
#9884
Rank
โ‚น0.50 B
Marketcap
โ‚น27.85
Share price
-2.22%
Change (1 day)
1.30%
Change (1 year)

BioNexus Gene Lab (BGLC) - Cash on Hand

Cash on Hand as of June 2024 : โ‚น0.45 Billion

According to BioNexus Gene Lab's latest financial reports the company has โ‚น0.45 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioNexus Gene Lab - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31โ‚น0.17 B10.91%
2021-12-31โ‚น0.15 B-22.46%
2020-12-31โ‚น0.20 B232.79%
2019-12-31โ‚น61.26 M-30.48%
2018-12-31โ‚น88.11 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น24.16 B 5,190.07%๐Ÿ‡บ๐Ÿ‡ธ USA